Clinical Trials Sponsored by Canceropôle Nord Ouest

Total 65 results

Centre Oscar Lambret
Canceropôle Nord Ouest

Not yet recruiting

Superiority Trial Evaluating Digitalized Information Media for Patients With Advanced Sarcomas Receiving Second Line Treatment. (ePPS-2202)

Sarcoma Metastatic | Locally Advanced Soft Tissue Sarcoma

France
Centre Francois Baclesse
Canceropôle Nord Ouest

Completed

Diagnostic Value of 18F-Choline PET/CT in Patients With a Thyroid Nodule With an Indeterminate Cytology: Pilot Study (CHOCOLATE)

Thyroid Gland

France
Centre Oscar Lambret
Canceropôle Nord Ouest

Active, not recruiting

Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer (STEREOLIVER)

Liver Metastases | Liver Cancer

France
Centre Francois Baclesse
Fondation de France; Cancéropôle Nord-Ouest

Completed

Pain of Patients, Suffering of Caregivers: Evaluation of the Benefit of Full Consciousness Meditation in Oncology (IMPLIC)

Pain | Cancer

France
University Hospital, Lille
Saint-Louis Hospital, Paris, France; Canceropôle Nord Ouest

Recruiting

Minimal Residual Disease Evaluation on Cryopreserved Ovarian Fragments in Younger Patients Treated for Acute Myeloid Leukemia (FERTILAM)

Acute Myeloid Leukemia

France
Centre Francois Baclesse
Canceropôle Nord Ouest; Ligue contre le cancer, France

Withdrawn

Evaluation of the Efficacy of Low-dose Acetylsalicylic Acid on Diarrhea Induced by Anti-cancer Targeted Therapies. (ASPIDIA)

Cancer

France
Centre Oscar Lambret
Canceropôle Nord Ouest; Groupement Interrégional de Recherche Clinique et d...

Recruiting

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring (SUR-CAN)

Glioma | Gastrointestinal Stromal Tumors | Neuroendocrine Tumors | Adenocarcinoma, Clear Cell | Carcinoma, Small Cell | Ovarian Germ Cell Tumor | Stage I Testicular Seminoma | Stage I Testicular Nonseminomatous Germ Cell Tumor | Borderline Ovarian Tumor | Sex Cord-Stromal Tumor | Mucinous Adenocarcinoma of... and other conditions

France
Gruppo Oncologico del Nord-Ovest

Recruiting

Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery (MERCURY)

Merkel Cell Carcinoma

Italy
Gruppo Oncologico del Nord-Ovest

Recruiting

Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer (POINT)

Nasopharyngeal Carcinoma

Italy
Gruppo Oncologico del Nord-Ovest

Recruiting

Tailored Sonidegib Schedule After Complete Response in BCC (SONIBEC)

Locally Advanced Basal Cell Carcinoma

Italy
Azienda USL Toscana Nord Ovest

Unknown

plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients

Covid-19 Pneumonia

Italy
Azienda USL Toscana Nord Ovest

Completed

Use of Binaural Beat Premedication in Elderly Submitted to Major Orthopedic Surgery

Postoperative Pain | Anxiety | Morphine Consumption

Italy
Gruppo Oncologico del Nord-Ovest

Unknown

Cetuximab Rechallenge in Irinotecan-pretreated mCRC, KRAS, NRAS and BRAF Wild-type Treated in 1st Line With Anti-EGFR Therapy (CRICKET). (CRICKET)

Metastatic Colorectal Cancer

Italy
Gruppo Oncologico del Nord-Ovest

Completed

First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer (FOIB)

Colorectal Cancer Metastatic
Gruppo Oncologico del Nord-Ovest

Recruiting

Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients (HAITI)

Colorectal Cancer Metastatic

Italy
Gruppo Oncologico del Nord-Ovest

Not yet recruiting

Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease (TRINITY)

Gastric Cancer | HER2-positive Gastric Cancer

Italy
Gruppo Oncologico del Nord-Ovest

Recruiting

CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence (PURITY)

Cholangiocarcinoma | Biliary Tract Cancer

Italy
Gruppo Oncologico del Nord-Ovest

Recruiting

TremelImumab aNd Durvalumab For the Non-operatIve Management (NOM) of MSI-high Resectable GC/GEJC. (INFINITY)

Gastric Cancer | Microsatellite Instability

Italy
Gruppo Oncologico del Nord-Ovest

Recruiting

Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients. (TriComB)

Colorectal Cancer Metastatic

Italy
Azienda USL Toscana Nord Ovest

Completed

Use of Binaural Beats for Colonoscopy

Pain

Italy
Gruppo Oncologico del Nord-Ovest

Unknown

Study of I Line FOLFOX + Panitumumab vs 5FU + Panitumumab in RAS and BRAF WT Metastatic Colorectal Cancer Elderly Patients (PANDA)

Elderly Metastatic Colorectal Cancer Patients

Italy
Gruppo Oncologico del Nord-Ovest

Unknown

Cetuximab + Avelumab or Avelumab Alone for Unresectable, Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (SCCAC) Progressed After at Least One Line of Systemic Treatment (CARACAS) (CARACAS)

Squamous Cell Anal Carcinoma

Italy
Gruppo Oncologico del Nord-Ovest

Completed

Induction Chemoterapy With Folfoxiri Plus Cetuxumab in Unresectable Colorectal Cancer Patient (MACBETH)

Metastatic Colorectal Cancer

Italy
Gruppo Oncologico del Nord-Ovest

Completed

Combination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer (TRIBE)

Colorectal Cancer

Italy
L'hôpital Nord-Ouest - Villefranche Villefranche...

Unknown

Assessment of Neurocognitive Rehabilitations of Inhibition of Disorders in ADHD in Children (ERNTITDAH) (ERNTITDAH)

ADHD

France
Gruppo Oncologico del Nord-Ovest

Recruiting

Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)

Colorectal Cancer | Resectable Colorectal Carcinoma

Italy
Gruppo Oncologico del Nord-Ovest

Recruiting

Induction and Maintenance Treatment With PARP Inhibitor and Immunotherapy in HPV-negative HNSCC (PRIME)

Head and Neck Squamous Cell Carcinoma

Italy
Gruppo Oncologico del Nord-Ovest

Recruiting

Targeting the Tumor Microenvironment in R/M SCCHN (CONFRONT)

Head and Neck Cancer

Italy
Gruppo Oncologico del Nord-Ovest

Active, not recruiting

Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29 (ShorTrip)

Locally Advanced Rectal Cancer

Italy
Azienda USL Toscana Nord Ovest

Completed

Use of a Low-cost Video Laryngoscope on Manikin

Airway Management

Italy
Azienda USL Toscana Nord Ovest

Active, not recruiting

Telemedicine for Home-based Management of Patients With Chronic Kidney Diseases and Comorbidities (NET-2018-12367206) (Telemechron)

Chronic Kidney Diseases

Italy
Gruppo Oncologico del Nord-Ovest

Completed

Immunotherapy In Locally Advanced Rectal Cancer (AVANA)

Colon Rectal Cancer

Italy
Gruppo Oncologico del Nord-Ovest

Active, not recruiting

AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients (AVETRIC)

Metastatic Colorectal Cancer

Italy
Gruppo Oncologico del Nord-Ovest

Completed

NIVolumab in Subjects With Recurrent or Metastatic Platinum-refrACTORy SCCHN (NIVACTOR)

Squamous Cell Carcinoma of Head and Neck

Italy
Gruppo Oncologico del Nord-Ovest

Completed

First Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTS (TRIPLETE)

Metastatic Colorectal Cancer

Italy
Gruppo Oncologico del Nord-Ovest

Unknown

Folfoxiri Plus Bev Followed by Reintroduction of Folfoxiri Plus Bev at Progression Versus Folfox Plus Bev Followed by Folfiri Plus Bev in mCRC (TRIBE2)

Metastatic Colorectal Cancer

Italy
Gruppo Oncologico del Nord-Ovest

Unknown

Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin (INTERCEPTOR)

Squamous Cell Carcinoma of the Head and Neck

Italy
Gruppo Oncologico del Nord-Ovest

Completed

FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Italy
Gruppo Oncologico del Nord-Ovest

Terminated

Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab (BEBYP)

Colorectal Cancer

Italy
Gruppo Oncologico del Nord-Ovest

Completed

FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal Cancer (TRIP)

Metastatic Colo-rectal Cancer

Italy
Alessandro Ghelardi

Not yet recruiting

Impact on Disease Relapse of HPV Vaccination in Women Treated With LEEP for Cervical Intraepithelial Neoplasia. HOPE9 (HOPE9)

Cervical Intraepithelial Neoplasia
Gruppo Oncologico del Nord-Ovest
Bayer; Amgen

Recruiting

PAnitumumab REchallenge Followed by REgorafenib Versus the Reverse Sequence (PARERE)

Colorectal Cancer

Italy
Centre Oscar Lambret
Institut National de la Santé Et de la Recherche Médicale, France; National... and other collaborators

Active, not recruiting

Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence. (SENTIRAD)

Endometrial Carcinoma

France
Azienda USL Toscana Nord Ovest
Auxilium Vitae Volterra

Completed

A Single Dry EEG Electrode Allows to Estimate of the Level of Anesthesia During Colonoscopy Sedation.

Anesthesia; Adverse Effect

Italy
Gruppo Oncologico del Nord-Ovest
Roche Pharma AG

Completed

FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients (AtezoTRIBE)

Metastatic Colorectal Cancer

Italy
Azienda USL Toscana Nord Ovest
Auxilium Vitae Volterra

Suspended

Non-pharmacological Treatment of Dyspnea in Chronic Obstructive Pulmonary Disease (COPD) (COPD)

Dyspnea

Italy
Centre Oscar Lambret
National Cancer Institute, France; Aix Marseille Université; University of Paris... and other collaborators

Unknown

Impact of Emotional Skills of Young Women and Their Partner on Adjustment to Cancer (KALICOU3)

Breast Cancer | Aging

France
Azienda USL Toscana Nord Ovest
Scuola Superiore Sant'Anna Pisa

Enrolling by invitation

Multimodal Instrumented Assessment of Post-stroke Elbow

Stroke | Spasticity, Muscle | Upper Limb

Italy
Gruppo Oncologico del Nord-Ovest
Seagen Inc.; Servier; Foundation Medicine

Recruiting

Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients (ERASE-CRC)

Stage II Colon Cancer | Stage III Colon Cancer | HER2-positive Colon Cancer | RAS Wild-type Colon Cancer

Italy
Gruppo Oncologico del Nord-Ovest
Mario Negri Institute for Pharmacological Research

Unknown

Denosumab In Ebv Nasopharyngeal Carcinoma As A Model For RankMediated Immunologic Modulation Of Virus-Related Tumours (Dern)

Nasopharyngeal Carcinoma | EBV Related Carcinoma

Italy

3

Subscribe